Testimony from North Dakota IP, Molly Howell, on House Bill 1377 which allows for immunization exemptions for any reason if a vaccine is not approved by the FDA and requires the vaccine must also be determined safe for at least one year, and manufacturers are required to be liable.
ND Testimony on HB 1377
Related Items
AIM Legislative Alert: Final FY 2023 Budget
On December 20, 2022, Congress released a final FY 2023 spending bill that includes a $31 million increase for the CDC’s Section 317 Immunization Program.
Updated COVID-19 Vaccine Booster Doses
Learn more about the two new Omicron (bivalent) vaccines, Pfizer and Moderna, which were recently authorized to be used as booster doses to help protect against the Omicron variants of the virus that causes COVID-19.
COVID-19 Reminder/Recall Postcard Templates
AIM developed four reminder/recall postcard templates for COVID-19 vaccine as part of the Vaccine Access and Training (VAT) project.